adult geriatric depression hispanic male with mdd

Decision Point One

Begin Effexor XR 37.5 mg orally daily

RESULTS OF DECISION POINT ONE

  • Client returns to clinic in four weeks
  • Client reports that there is no change in depressive symptoms at all

RESULTS OF DECISION POINT ONE

  • Client returns to clinic in four weeks
  • Client reports that there is no change in depressive symptoms at all

Decision Point Two

RESULTS OF DECISION POINT TWO

  • Client returns to clinic in four weeks
  • Client reports an improvement in depressive symptoms
  • Montgomery- Asberg Depression Rating Scale (MADRS) decreased from 51 to 38 (25% reduction)

Decision Point Three

Increase dose to 112.5 mg orally daily

Guidance to Student

At this point, the PMHNP would have two choices to discuss with the client- the current dose of drug can be maintained if the client is feeling better and is not offering any complaints of side effects. The dose can also be increased at this point, but the PMHNP must counsel client regarding the possibility of side effects. The use of an augmenting agent is not appropriate at this time as we have not reached a maximum dose with Effexor (in fact, 75 mg is still a relatively small dose), displaying primarily SSRI properties only (recall that at lower doses, Effexor exerts a greater effect on serotonergic receptors than norepinephrine at low doses).

 
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Looking for a Similar Assignment? Our Experts can help. Use the coupon code SAVE30 to get your first order at 30% off!